MagtraceTM and Sentimag(R) Magnetic Locatization System
Endomagnetics Ltd., · Decision date May 18, 2026
What did the FDA decide?
FDA records P160053/S012 as a supplement to PMA P160053, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 18, 2026.
FDA approval order statement
approval for the generation of a new UDI and reference number for Magtrace products sold specifically in the United States to satisfy traceability and UDI requirements
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- General, Plastic Surgery
- Decision date
- May 18, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P160053/S012
- Regulatory pathway
- PMA supplement
- Applicant
- Endomagnetics Ltd.,
- Product code
- PUV
- Decision code
- OK30
- Decision date
- May 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lymph node location system during sentinel biopsy procedure.
- Applicant
- Endomagnetics Ltd.,
- Product code
- PUV
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P160053/S012 received
Application receipt date recorded by FDA.
P160053/S012 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P160053. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Endomagnetics Ltd.,
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 330 Cambridge Science Park Milton Rd., Cambridge, CB4 0WN
Sources and methodology
- Original FDA record: P160053/S012
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records